UNITEDHEALTH GROUP INC (UNH) Stock Analysis

UNITEDHEALTH GROUP INC (UNH) Stock Analysis

Analysis from 10-Q filed 2025-10-28. Data as of Q4 2025.

Overall Grade: F (Concerning)

UNITEDHEALTH GROUP INC faces challenges in financial performance that warrant careful analysis.

Metric Value Context
ROIC N/A Below expectations
FCF Margin 3.6% Cash flow pressure

Investment Thesis: Financial metrics indicate concerning business quality with areas requiring attention.

Explore UNITEDHEALTH GROUP INC: Earnings History | Filing Intelligence | ROIC Analysis


Profitability: UNITEDHEALTH GROUP INC earns N/A ROIC

UNITEDHEALTH GROUP INC's trailing-twelve-month ROIC of N/A (sector median: 7.3%). Source: 10-Q filed 2025-10-28.

Metric UNH Rating Context
Return on Invested Capital (ROIC) N/A Red flag Below sector median of 7.3%

Cash Flow: UNITEDHEALTH GROUP INC generates $16.1B FCF at 3.6% margin, positive NaN/8 quarters

UNITEDHEALTH GROUP INC generated $16.1B in free cash flow (TTM), a 3.6% FCF margin, a margin that ranks Bottom 50% in Financials. Operating cash flow exceeds net income by 1.6x, indicating high earnings quality. FCF was positive in N/A of the last 8 quarters. Source: 10-Q filed 2025-10-28.

Metric UNH Rating Context
Free Cash Flow Margin 3.6% Warning Thin cash margins
Free Cash Flow (TTM) $16.1B Good Positive cash generation
OCF/Net Income 1.6x Excellent High earnings quality
FCF Consistency (8Q) N/A Warning Variable cash flow

Balance Sheet Analysis for UNITEDHEALTH GROUP INC

Total debt of $78.4B offset by $28.1B in cash. Source: 10-Q filed 2025-10-28.

Metric UNH Rating Context
Net Cash Position $-50.3B Warning Net debt position

Valuation: UNITEDHEALTH GROUP INC trades at 24.9x earnings

UNITEDHEALTH GROUP INC trades at a P/E of 24.9x. Free cash flow yield of 5.4% offers attractive cash returns relative to price.

Metric UNH Rating Context
P/E Ratio 24.9x Adequate Premium valuation
EV/Sales 0.8x Excellent Attractive revenue multiple
FCF Yield 5.4% Good Attractive cash return
Dividend Yield 2.6% Adequate Growth focus over income

Capital Allocation: UNITEDHEALTH GROUP INC returns 4.5% shareholder yield

UNITEDHEALTH GROUP INC's total shareholder yield is 4.5% (dividends 2.6% + buybacks 1.8%). Source: 10-Q filed 2025-10-28.

Metric UNH Rating Context
Total Shareholder Yield 4.5% Good Dividend + buyback yield combined
Buyback Yield 1.8% Adequate Minimal buyback activity
Total Capital Returned (TTM) $13.5B Good Dividends + buybacks returned to shareholders

Sector Rankings

Metric Value Percentile vs Median
Free Cash Flow Margin 3.6% Bottom 50% 0.2x below
P/E Ratio 24.9x N/A -

Financial Scorecard

Metric UNH Rating Sector Context
Free Cash Flow Margin 3.6% Warning Bottom 50% of sector (median: 21.7%)
P/E Ratio (Price-to-Earnings) 24.9x Adequate Fair value
Free Cash Flow Yield 5.4% Good Solid cash yield

Frequently Asked Questions

Q: What is UNITEDHEALTH GROUP INC's Return on Invested Capital (ROIC)?

UNITEDHEALTH GROUP INC (UNH) has a trailing twelve-month Return on Invested Capital (ROIC) of N/A. This compares below the sector median of 7.3%. An ROIC below 8% suggests the company may be destroying shareholder value.

Q: What is UNITEDHEALTH GROUP INC's Free Cash Flow Margin?

UNITEDHEALTH GROUP INC (UNH) has a free cash flow margin of 3.6%, generating $16.1 billion in free cash flow over the trailing twelve months. A thin FCF margin may indicate heavy reinvestment or operational challenges.

Q: Is UNITEDHEALTH GROUP INC stock overvalued or undervalued?

UNITEDHEALTH GROUP INC (UNH) trades at a P/E ratio of 24.9x, which is above the sector median of N/A. The EV/Sales multiple is 0.8x. Free cash flow yield is 5.4%, which is in line with market averages.

Q: Does UNITEDHEALTH GROUP INC pay a dividend?

UNITEDHEALTH GROUP INC (UNH) currently pays a dividend yield of 2.6%. Including share buybacks, the total shareholder yield is 4.5%. This yield is moderate, suggesting a balance between income and growth reinvestment.

Q: What is UNITEDHEALTH GROUP INC's revenue and earnings growth?

UNITEDHEALTH GROUP INC (UNH) grew revenue by 11.8% year-over-year. Earnings per share decreased by 14.8% compared to the prior year. Solid growth above 10% suggests healthy business momentum.

Q: Is UNITEDHEALTH GROUP INC buying back stock?

UNITEDHEALTH GROUP INC (UNH) repurchased $5.5 billion of stock over the trailing twelve months. This represents a buyback yield of 1.8%.

Q: How does UNITEDHEALTH GROUP INC compare to competitors in Financials?

Compared to other companies in Financials, UNITEDHEALTH GROUP INC (UNH) shows: ROIC of N/A is below the sector median of 7.3% (NaNx median). FCF margin of 3.6% trails the sector median of 21.7% (Bottom 26% of sector). These rankings are based on MetricDuck's analysis of all Financials companies with available SEC filings.

Q: What warning signs should I watch for with UNITEDHEALTH GROUP INC?

Investors in UNITEDHEALTH GROUP INC (UNH) should monitor these potential warning signs: 1) FCF margin is thin at 3.6%, leaving limited buffer for economic downturns. Regular monitoring of SEC filings and quarterly trends is recommended.


Data Source: Data sourced from 10-Q filed 2025-10-28. TTM metrics as of Q4 2025.

Methodology: Financial metrics calculated from SEC 10-K and 10-Q filings using standardized formulas. Sector comparisons use peer group based on SIC code.

Scope: This analysis covers SEC filing fundamentals — profitability, cash flow, balance sheet, and valuation metrics. For analyst estimates and price targets, consult sell-side research.

This analysis is for informational purposes only and does not constitute investment advice.